Metraipolis › archive › dc_f67290ecd670
Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences — Europe PMC PMID:40202860
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40202860
- DOI
- 10.1093/cid/ciaf116
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:23:16.941Z
- SHA-256 of the archived text
c963bc282490f465a1fa85653ef06cb3155cae712219dc45a9159439398325dd- Stable URL of this page
https://metraipolis.com/documento/dc_f67290ecd670
How to cite
Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences — Europe PMC PMID:40202860 — Europe PMC (en), https://europepmc.org/article/MED/40202860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f67290ecd670 (Metraipolis archive dc_f67290ecd670, sha256 c963bc282490f465a1fa85653ef06cb3155cae712219dc45a9159439398325dd)
BibTeX
@misc{dcf67290ecd670,
title = {Lenacapavir for HIV Prevention: A Commitment to Equitable Access and Partnership by Gilead Sciences — Europe PMC PMID:40202860},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40202860},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f67290ecd670; sha256 c963bc282490f465a1fa85653ef06cb3155cae712219dc45a9159439398325dd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40202860. Agents can read the archived copy with the MCP tool read_document.